Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

IDXX IDEXX Laboratories Inc

325.800
-6.010-1.81%
Close 09/30 16:00 ET
325.8000.0000.00%
Post Mkt Price 09/30 16:38 ET
High
342.410
Open
333.590
Turnover
186.46M
Low
325.570
Pre Close
331.810
Volume
563.57K
Market Cap
27.12B
P/E(TTM)
42.15
52wk High
672.930
Shares
83.25M
P/E(Static)
37.88
52wk Low
318.500
Float Cap
26.85B
Bid/Ask %
0.00%
Historical High
706.950
Shs Float
82.41M
Volume Ratio
0.93
Historical Low
2.313
Dividend TTM
--
Div Yield TTM
--
P/B
59.36
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.68%
Amplitude
5.08%
Avg Price
330.858
Lot Size
1
Float Cap
26.85B
Bid/Ask %
0.00%
Historical High
706.950
Shs Float
82.41M
Volume Ratio
0.93
Historical Low
2.313
Dividend TTM
--
P/B
59.36
Dividend LFY
--
Turnover Ratio
0.68%
Amplitude
5.08%
Avg Price
330.858
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy and water testing markets. It operates through the following segments: Companion Animal Group (CAG), Water, Livestock, Poultry and Dairy (LPD), and Other. The CAG segment provides diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment offers innovative testing solutions for easy, rapid, and accurate detection and quantification of various microbiological parameters in water. The LPD segment develops diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve producer efficiency, and to ensure the quality and safety of milk and food. The Other segment is composed of products for the human point-of-care medical diagnostics market with its out-licensing arrangements. The company was founded by David Evans Shaw on December 19, 1983, and is headquartered in Westbrook, ME.
CEO: Mr. Jonathan J. Mazelsky
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...